Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Gynecologic 1Genitourinary 1Gastrointestinal 1CNS 1

Conditions

Vulvar Neoplasms 1Uterine Cervical Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Salivary Gland Neoplasms 1Penile Neoplasms 1Head and Neck Neoplasms 1Esthesioneuroblastoma, Olfactory 1Esophageal Neoplasms 1Anus Neoplasms 1

Interventions

Fluorouracil 11Cisplatin 10Radiotherapy 9Paclitaxel 7Trastuzumab 5Erlotinib Hydrochloride 5Specimen Handling 4Taxes 3Radiation 3Nivolumab 3Magnetic Resonance Spectroscopy 3Leucovorin 3Irinotecan 3Carboplatin 3trastuzumab biosimilar HLX02 2entinostat 2alvocidib 2Psychiatric Rehabilitation 2Plicamycin 2PF-05280014 2Oxaliplatin 2Ontruzant 2Ogivri 2Neoadjuvant Therapy 2Microarray Analysis 2Epirubicin 2Decitabine 2Celecoxib 2CT-P6 2Brachytherapy 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Esophageal Neoplasms × E6 protein, Human papillomavirus type 16 × Clear all
NCT00019110 2015-04-29

Vaccine Therapy in Treating Patients With Advanced or Recurrent Cancer

National Cancer Institute (NCI)

Phase 1 Completed
CNSGastrointestinalGenitourinaryGynecologicHead & Neck

Squamous Cell Carcinoma of Head and Neck, Anus Neoplasms, Uterine Cervical Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Penile Neoplasms, Salivary Gland Neoplasms, Vulvar Neoplasms, Esthesioneuroblastoma, Olfactory

Data powered by HemOnc (CC BY 4.0) Colophon âš¡